-
Listen up if you want to be successful
Two friends were walking down a busy street one evening when one paused and said, “Listen to those crickets chirping.” “What crickets?” said the other man. “I don’t hear any crickets. Hey, you!” He waved down a woman passing by. “Do you hear crickets around here?” “No,” the woman said, and went on her way.…
-
Freedom of Speech in Australia and the HPV Vaccine
Editor’s Note: The incident described in the material below is presented by Judy Wilyman, a PhD candidate. As a PhD student, she of all people is mentored in the correct aspects of developing medical evidence. As she has developed her thesis she has found many shortfalls in official evidence, particularly that surrounding the hysteria that…
-
Report on Government Services 2015 Volume E: Health – the Silo You Will Struggle to Live In
This year marks the twentieth edition of the Report on Government Services – a remarkable milestone for a unique report providing comparative information on the performance of government services (so says the government). The Report is produced by the Productivity Commission for an inter-governmental Steering Committee. Peter Harris, Chairman of the Productivity Commission and the…
-
NAPSA generosity shows the future of pharmacy is in good hands Pharmacists’ Support Service 1995 to 2015 – celebrating 20 years
From small beginnings in Victoria in 1995 the Pharmacists’ Support Service (PSS) is now celebrating 20 years of supporting the profession. This includes expansion to support all Australian pharmacists, pharmacy interns and pharmacy students. To acknowledge this achievement and to assist in funding the expanded service PSS is aiming to raise $20,000 through fundraising activities…
-
PSA Media Releases – 1. New Tas President 2. Canberra Office Relocation 3. WA Immunisation Training 4. PSA Budget Submissions
February 13, 2015 Rachel Dienaar elected new President of Tasmanian Branch of PSA The Tasmanian Branch of the Pharmaceutical Society of Australia has announced the election of a new President, Rachel Dienaar, replacing Dr Shane Jackson who has resigned from the branch committee and the position of President recently. Ms Dienaar is a currently practising…
-
ASMI Media Release – Fine Tune Non-Prescription Regulations
ASMI calls on Federal Government to fine tune regulatory settings for nonprescription medicines industry 11 February 2015 – The Australian Self Medication Industry (ASMI) today urged the Federal Government to establish a regulatory framework for the non-prescription medicines industry that balances the protection of consumers with regulatory settings that encourage industry to invest in new…
-
NPS Media Release – New Fatigue Tool
NEW TOOL TO TAILOR INFORMATION FOR PATIENTS PRESENTING WITH FATIGUE In Australia, people often seek medical advice because of fatigue. However it is often not associated with underlying disease,particularly in young to middle aged adults, and may remain unexplained. Managing patients with this symptom can present a range of challenges for general practitioners. As part…
-
EDITORIAL for Monday 9 February, 2015
Welcome to this weeks’ edition of i2P E-magazine (Information to Pharmacists) dated Monday 9 February 2015. While we have the greatest respect for the skills of our doctors and nurses there is always a point of competition at the boundaries of our professions where we have to fight each other to define these boundaries. Generally,…
-
The Patient-Centred Primary Care Collaborative
This article contains an evidence-based report on US physician-led Patient Centred Primary Care (PCPC) “Homes” that are likely to be modeled and supported here in Australia. i2P would simply like to expand the debate for pharmacist-led models that will initially evolve from clinics that will be established in community pharmacies. Many of these clinics will be…
-
Withdrawn drugs – our patients deserve better
Patients are dying because of year-long delays in withdrawing dangerous drugs from the global market, according to Oxford University researchers. They say that the danger could be reduced by better reporting of the deaths, and quicker action by manufacturers and regulators. Unbelievably, the time between the first death being reported, and the drug being withdrawn,…